Project Details
Description
Low-Cost, Broad-Spectrum Cancer Vaccine Targeting Human Papillomavirus Low- Cost, Broad- Spectrum Cancer Vaccine Targeting Human Papillomavirus
Status | Active |
---|---|
Effective start/end date | 5/11/22 → 3/31/23 |
Funding
- HHS-NIH: National Cancer Institute (NCI): $130,027.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.